       Document 0562
 DOCN  M9630562
 TI    Evaluating the cost-effectiveness of pharmacologic therapy: where we've
       been and where we're going.
 DT    9603
 AU    Epstein AM; Department of Medicine, Brigham and Women's Hospital,
       Boston,; Massachusetts, USA.
 SO    J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 4:S1-5. Unique
       Identifier : AIDSLINE MED/96075582
 DE    Acquired Immunodeficiency Syndrome/DRUG THERAPY/ECONOMICS  Antiviral
       Agents/ECONOMICS/THERAPEUTIC USE  Cost-Benefit
       Analysis/STANDARDS/*TRENDS  Ethics, Medical  Evaluation Studies  Human
       JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

